Industrial Policy
India's PLI Scheme: A New Engine for Global Manufacturing Shift and Supply Chain Restructuring
India's Production Linked Incentive (PLI) scheme has attracted over ₹2.40 lakh crore in investments, created 1.415 million jobs, and driven exports worth ₹15.2 lakh crore. The scheme is accelerating India's integration into global value chains, reshaping the manufacturing landscape of key industries such as electronics, pharmaceuticals, and medical devices. This article analyzes how the PLI scheme drives supply chain diversification and industrial upgrading from a global manufacturing perspective.
India's PLI Scheme: A New Engine for Global Manufacturing Shift and Supply Chain Restructuring
Against the backdrop of accelerating diversification of global supply chains and fierce competition among nations to attract advanced manufacturing, India's Production Linked Incentive (PLI) scheme has delivered impressive results. As of March 2026, the scheme has attracted cumulative investments exceeding ₹2.40 trillion (about ₹2.4 trillion) across 14 key sectors, created 1.415 million direct and indirect jobs, and driven exports of over ₹15.2 trillion. These figures not only reflect a leap in India's manufacturing capabilities but also signify a structural adjustment in the global industrial layout.
From Policy to Industry: Scale and Mechanism of PLI
The PLI scheme was launched by the Indian government in 2020 with an initial financial outlay of ₹1.91 trillion, covering 14 sectors including electronics, pharmaceuticals, automobiles, textiles, white goods, etc. The Department for Promotion of Industry and Internal Trade (DPIIT) oversees overall coordination, while respective administrative ministries implement the scheme. Unlike traditional subsidies, PLI adopts an "incremental incentive" model—companies must meet certain production or sales increment thresholds to receive rewards. This design reduces fiscal burden while directly stimulating capacity expansion.
The Indian government regularly reviews scheme implementation through "ministerial groups" and dynamically adjusts rules based on corporate feedback, such as relaxing eligibility conditions and optimizing monitoring mechanisms. This flexible policy iteration is one of the key factors in PLI's success.
Electronics Manufacturing: Import Substitution and Export Boom
The electronics sector is the most standout segment of the PLI scheme. Since the scheme's launch, India's mobile phone production has grown by approximately 2.4 times, mobile phone imports have plummeted by 77%, and 99.2% of mobile phones used domestically are now manufactured locally. This means India has transformed from a net importer of mobile phones to a largely self-sufficient manufacturing base. In terms of exports, global giants such as Apple and Samsung have massively expanded production in India, making the country the world's second-largest mobile phone manufacturer.
The root of this transformation lies in the PLI scheme precisely targeting the window of opportunity for restructuring the global electronics supply chain. Trade frictions between the US and China, along with supply disruptions caused by the pandemic, have prompted multinational corporations to seek "China+1" options. India, with its labor costs, policy incentives, and gradually improving supply chain infrastructure, has emerged as a preferred destination.
Pharmaceuticals and Medical Devices: Localization from Generics to High-End Equipment
In the pharmaceutical sector, the PLI scheme has driven cumulative sales exceeding ₹3.64 trillion, and for the first time, 1,931 types of drugs have been produced locally, including 191 active pharmaceutical ingredients (APIs). In 26 key APIs, India has established a production capacity of approximately 55,000 tonnes, reducing dependence on specific countries. For example, the domestic production of paracetamol (acetaminophen) and the antibiotic levofloxacin has accelerated significantly.
Medical device manufacturing has also achieved breakthroughs.Medical device manufacturing has also achieved breakthroughs. High-end equipment such as CT scanners, MRI systems, catheterization labs, and ultrasound devices have begun localized production, with 22 companies already in operation and 55 unique devices certified. This marks India’s upgrade from low-end consumables to high-value-added medical device manufacturing.
Telecommunications and White Goods: Technological Autonomy and Supply Chain DeepeningIndia's PLI scheme is no longer just a set of subsidies; it is becoming a catalyst for the global manufacturing shift. Over the next five years, as investment continues to pour in and industrial chains deepen, India is expected to capture 10%-15% of global production capacity in key sectors such as electronics, pharmaceuticals, white goods, and automobiles. For global companies seeking supply chain resilience, this means a reliable new node is taking shape.
Global manufacturing analysts should closely monitor the next phase of the PLI scheme's expansion—whether it extends into semiconductors, green energy, and AI hardware will determine if India can upgrade from an "assembly base" to a "knowledge-driven manufacturing engine." The success of industrial policy ultimately depends on implementation efficiency and supporting reforms. India is providing its own answer.
Editorial trail · manufbrief
manufbrief frames this note through Concise manufacturing intelligence covering industry briefs, supply chains, industrial policy, regional ind...: Source links should be opened before the summary is reused. dates, names and status changes still need checking; Industry Briefs / Supply Chain / Industrial Policy explains the local editorial angle.